Singapore Medical Group acquires stake in local aesthetics clinic, proposes rights issue
SMG plans for mergers and acquisitions, business expansion
Nisha Ramchandani
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
CATALIST-LISTED Singapore Medical Group (SMG) is acquiring an 85 per cent stake in Pheniks which operates local aesthetics clinic SW1, with plans to expand the brand across the region.
SMG will pay up up to S$6.5 million, with up to S$3 million paid in cash over three years, while the balance sum will be satisfied through the issuance of some 6.05 million new shares at S$0.578 per share.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Singaporeans can now buy record amount of yen per Singdollar
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain